{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T18:00:59Z","timestamp":1772042459451,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Fabry disease (FD), an X-linked lysosomal storage disorder, is caused by a reduced activity of the lysosomal enzyme \u03b1-galactosidase A. The disorder ultimately leads to organ damage (including renal failure) in males and females. However, heterozygous females usually present a milder phenotype with a later onset and a slower progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A combined enzymatic and genetic strategy was used, measuring the activity of \u03b1-galactosidase A and genotyping the \u03b1-galactosidase A gene (<jats:italic>GLA<\/jats:italic>) in dried blood samples (DBS) of 911 patients undergoing haemodialysis in centers across Spain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>\n              <jats:italic>GLA<\/jats:italic> alterations were found in seven unrelated patients (4 males and 3 females). Two novel mutations (p.Gly346AlafsX347 and p.Val199GlyfsX203) were identified as well as a previously described mutation, R118C. The R118C mutation was present in 60% of unrelated patients with <jats:italic>GLA<\/jats:italic> causal mutations. The D313Y alteration, considered by some authors as a pseudo-deficiency allele, was also found in two out of seven patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Excluding the controversial D313Y alteration, FD presents a frequency of one in 182 individuals (0.55%) within this population of males and females undergoing haemodialysis. Moreover, our findings suggest that a number of patients with unexplained and atypical symptoms of renal disease may have FD. Screening programmes for FD in populations of individuals presenting severe kidney dysfunction, cardiac alterations or cerebrovascular disease may lead to the diagnosis of FD in those patients, the study of their families and eventually the implementation of a specific therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2350-11-19","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T07:16:38Z","timestamp":1265094998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Frequency of Fabry disease in male and female haemodialysis patients in Spain"],"prefix":"10.1186","volume":"11","author":[{"given":"Paulo","family":"Gaspar","sequence":"first","affiliation":[]},{"given":"Julio","family":"Herrera","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Sebasti\u00e1n","family":"Cerezo","sequence":"additional","affiliation":[]},{"given":"Rodrigo","family":"Delgado","sequence":"additional","affiliation":[]},{"given":"Carlos F","family":"Andrade","sequence":"additional","affiliation":[]},{"given":"Ram\u00f3n","family":"Forascepi","sequence":"additional","affiliation":[]},{"given":"Juan","family":"Macias","sequence":"additional","affiliation":[]},{"given":"Maria D","family":"del Pino","sequence":"additional","affiliation":[]},{"given":"Maria D","family":"Prados","sequence":"additional","affiliation":[]},{"given":"Pilar R","family":"de Alegria","sequence":"additional","affiliation":[]},{"given":"Gerardo","family":"Torres","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Vidau","sequence":"additional","affiliation":[]},{"given":"Maria C","family":"S\u00e1-Miranda","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,2,1]]},"reference":[{"key":"580_CR1","first-page":"3733","volume-title":"The metabolic and molecular basis of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM: \u03b1-Galactosidase A deficiency: FD. The metabolic and molecular basis of inherited disease. Edited by: Scriver CR, Beaud Sly WS, Valle D, Kinzler KE, Vogelstein B. 2001, McGraw-Hill, New York, USA, 3733-3774."},{"issue":"1","key":"580_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","volume":"122","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R: FD. Pharmacol Ther. 2009, 122 (1): 65-77. 10.1016\/j.pharmthera.2009.01.003.","journal-title":"Pharmacol Ther"},{"key":"580_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/08035320600618809","volume":"95","author":"EM Maier","year":"2006","unstructured":"Maier EM, Osterrieder S, Whybra C, et al: Disease manifestations and X inactivation in heterozygous females with FD. Acta Paediatr Suppl. 2006, 95: 30-38. 10.1080\/08035320600618809.","journal-title":"Acta Paediatr Suppl"},{"key":"580_CR4","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/0272-6386(95)90061-6","volume":"26","author":"M Fukushima","year":"1995","unstructured":"Fukushima M, Tsuchiyama Y, Nakato T, et al: A female heterozygous patient with Fabry's disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody. Am J Kidney Dis. 1995, 26: 952-955. 10.1016\/0272-6386(95)90061-6.","journal-title":"Am J Kidney Dis"},{"key":"580_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/BF01606034","volume":"417","author":"M Elleder","year":"1990","unstructured":"Elleder M, Bradov\u00e1 V, Sm\u00edd F, et al: Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol. 1990, 417: 449-455. 10.1007\/BF01606034.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"580_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJM199102073240607","volume":"324","author":"W Von Scheidt","year":"1991","unstructured":"Von Scheidt W, Eng CM, Fitzmaurice TF, et al: An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med. 1991, 324: 395-399.","journal-title":"N Engl J Med"},{"key":"580_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1399-0004.1991.tb03018.x","volume":"39","author":"Y Nagao","year":"1991","unstructured":"Nagao Y, Nakashima H, Fukuhara Y, et al: Hypertrophic cardiomyopathy in late-onset variant of FD with high residual activity of \u03b1-galactosidase A. Clin Genet. 1991, 39: 233-237.","journal-title":"Clin Genet"},{"key":"580_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, et al: An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med. 1995, 333: 288-293. 10.1056\/NEJM199508033330504.","journal-title":"N Engl J Med"},{"key":"580_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.semnephrol.2004.06.024","volume":"24","author":"A Sessa","year":"2004","unstructured":"Sessa A, Meroni M, Battini G, Righetti M, Mignani R: Chronic renal failure, dialysis, and renal transplantation in Anderson-FD. Semin Nephrol. 2004, 24: 532-536. 10.1016\/j.semnephrol.2004.06.024.","journal-title":"Semin Nephrol"},{"key":"580_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF: Prevalence of lysosomal storage disorders. JAMA. 1999, 281: 249-254. 10.1001\/jama.281.3.249.","journal-title":"JAMA"},{"key":"580_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","volume":"12","author":"R Pinto","year":"2004","unstructured":"Pinto R, Caseiro C, Lemos M, et al: Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet. 2004, 12: 87-92. 10.1038\/sj.ejhg.5201044.","journal-title":"Eur J Hum Genet"},{"key":"580_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1525-1470.1995.tb00161.x","volume":"12","author":"ED Shelley","year":"1995","unstructured":"Shelley ED, Shelley WB, Kurczynski TW: Painful fingers, heat intolerance, and telangiectases of the ear: easily ignored childhood signs of FD. Pediatr Dermatol. 1995, 12: 215-219. 10.1111\/j.1525-1470.1995.tb00161.x.","journal-title":"Pediatr Dermatol"},{"key":"580_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M, Pagliardini S, Yasuda M, et al: High incidence of later-onset FD revealed by newborn screening. Am J Hum Genet. 2006, 79: 31-40. 10.1086\/504601.","journal-title":"Am J Hum Genet"},{"key":"580_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao S, Kodama C, Takenaka T, et al: FD: detection of undiagnosed hemodialysis patients and identification of a \"renal variant\" phenotype. Kidney Int. 2003, 64: 801-807. 10.1046\/j.1523-1755.2003.00160.x.","journal-title":"Kidney Int"},{"key":"580_CR15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko P, Kramar R, Devrnja D, et al: Results of a nationwide screening for Anderson-FD among dialysis patients. J Am Soc Nephrol. 2004, 15: 1323-1329. 10.1097\/01.ASN.0000124671.61963.1E. Erratum in: J Am Soc Nephrol 2004; 15: 1a. J Am Soc Nephrol 2004;15: A4,","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"580_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/ndt\/gfl528","volume":"22","author":"M Merta","year":"2007","unstructured":"Merta M, Reiterova J, Ledvinova J, Poupetov\u00e1 H, Dobrovolny R, Rysav\u00e1 R, Maixnerov\u00e1 D, Bultas J, Mot\u00e1n J, Slivkova J, Sobotova D, Smrzova J, Tesar V: A nationwide blood spot screening study for FD in the Czech Republic haemodialysis patient population. Nephrol Dial Transplant. 2007, 22 (1): 179-86. 10.1093\/ndt\/gfl528.","journal-title":"Nephrol Dial Transplant"},{"key":"580_CR17","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","volume":"50","author":"L Monserrat","year":"2007","unstructured":"Monserrat L, Gimeno-Blanes JR, Mar\u00edn F, et al: Prevalence of FD in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007, 50: 2399-2403. 10.1016\/j.jacc.2007.06.062.","journal-title":"J Am Coll Cardiol"},{"key":"580_CR18","first-page":"1186","volume":"53","author":"CM Eng","year":"1993","unstructured":"Eng CM, Resnick-Silverman LA, Niehaus DJ, Astrin KH, Desnick RJ: Nature and frequency of mutations in the \u03b1-galactosidase A gene that cause FD. Am J Hum Genet. 1993, 53: 1186-1197.","journal-title":"Am J Hum Genet"},{"key":"580_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1096-7192(03)00136-7","volume":"80","author":"R Froissart","year":"2003","unstructured":"Froissart R, Guffon N, Vanier MT, Desnick RJ, Maire I: FD: D313Y is an \u03b1-galactosidase A sequence variant that causes pseudodeficient activity in plasma. Mol Genet Metab. 2003, 80: 307-314. 10.1016\/S1096-7192(03)00136-7.","journal-title":"Mol Genet Metab"},{"key":"580_CR20","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1161\/CIRCULATIONAHA.105.593558","volume":"113","author":"H Morita","year":"2006","unstructured":"Morita H, Larson MG, Barr SC, et al: Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation. 2006, 113: 2697-2705. 10.1161\/CIRCULATIONAHA.105.593558.","journal-title":"Circulation"},{"issue":"4","key":"580_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/14764170802275832","volume":"10","author":"P Morais","year":"2008","unstructured":"Morais P, Santos AL, Baudrier T, Mota AV, Oliveira JP, Azevedo F: Angiokeratomas of Fabry successfully treated with intense pulsed light. J Cosmet Laser Ther. 2008, 10 (4): 218-22. 10.1080\/14764170802275832.","journal-title":"J Cosmet Laser Ther"},{"issue":"6","key":"580_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/humu.10275","volume":"22","author":"M Yasuda","year":"2003","unstructured":"Yasuda M, Shabbeer J, Benson SD, Maire I, Burnett RM, Desnick RJ: FD: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele. Hum Mutat. 2003, 22 (6): 486-92. 10.1002\/humu.10275.","journal-title":"Hum Mutat"},{"key":"580_CR23","volume-title":"J Med Genet","author":"GE Linthorst","year":"2009","unstructured":"Linthorst GE, Bouwman MG, Wijburg FA, Aerts JM, Poorthuis BJ: Hollak CE Screening for FD in high risk populations: a systematic review. J Med Genet. 2009,"},{"key":"580_CR24","first-page":"157","volume":"81","author":"RJ Desnick","year":"1973","unstructured":"Desnick RJ, Allen KY, Desnick SJ, Raman MK, Bernlohr RW, Krivit W: Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. \u0391-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med. 1973, 81: 157-171.","journal-title":"J Lab Clin Med"},{"key":"580_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/humu.20144","volume":"25","author":"J Shabbeer","year":"2005","unstructured":"Shabbeer J, Robinson M, Desnick RJ: Detection of \u03b1-galactosidase a mutations causing FD by denaturing high performance liquid chromatography. Hum Mutat. 2005, 25: 299-305. 10.1002\/humu.20144.","journal-title":"Hum Mutat"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-11-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-11-19\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-11-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-11-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T03:58:54Z","timestamp":1630468734000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-11-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["580"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-11-19","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,1]]},"assertion":[{"value":"21 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"19"}}